Albumin Market

Transcription

Albumin Market

Transparency Market
Research
Albumin Market - Global Industry Analysis, Size, Share,
Volume, Growth, Trends and Forecast 2014 - 2020
Published Date
2015-01-14
90 Page Report
Buy Now
Request Sample
Press Release
Albumin (Excipient) Market Expected to Reach USD 0.8 Billion
Globally in 2020
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
[email protected]
Albumin Market
REPORT DESCRIPTION
Albumin Market - Global Industry Analysis, Size, Share, Volume, Growth,
Trends and Forecast 2014 – 2020
Appropriate selection of excipients during the new product development is one of the critical in
the pharmaceutical formulations. Criteria for selection of suitable excipient depend on the
physical, chemical and biological properties of the excipient. Primarily, it should help stabilize
and protect the drug/active pharmaceutical ingredient (API) in the formulation against
degradation, oxidation or aggregation, during manufacturing, transport and storage.
Preformulation studies comprise investigation of drug-excipient interactions that help in selection
of appropriate excipients to achieve the desired properties for the final drug product. Albumin is
a well characterized protein and functions as a therapeutic, diagnostic agent, as well as an
excipient. As an excipient, albumin has wide applications in drug formulation, drug delivery,
vaccine manufacturing and as a component of media in vaccine production. Stable nature of
albumin makes its handling and storage easier than other proteins, making it suitable for use as
an excipient. Albumin due to its intrinsic stability can be heated at 60°C for 10 hours facilitating
virus inactivation during manufacturing.
Browse the full Albumin Market Report at :
http://www.transparencymarketresearch.com/albumin-market.html
This report studies the global market for albumin encompassing type, applications and
geography. Types of albumin include human serum albumin, bovine serum albumin and
recombinant albumin. Major applications for albumin as an excipient comprise drug formulation
and drug delivery, vaccines and component of medium. Each of these segments has been
analyzed in detail from market trends and recent developments to future outlook and
opportunities. The report provides the albumin market size in terms of value (USD million) and
volume (kg) for each segment and sub-segment for the period from 2012 to 2020, considering
the macro- and micro environmental factors. In addition, the compounded annual growth rate
(CAGR) of the overall albumin market and the segments has also been provided in the report for
2
Albumin Market
the forecast period 2014 to 2020, considering 2012 as historical year and 2013 as the base year.
The global albumin market report also includes an elaborate executive summary, which covers a
market snapshot representing key findings from the study.
Browse the full Albumin Market press release at :
http://www.transparencymarketresearch.com/pressrelease/albuminmarket.htm
Geographically, the global albumin market has been segmented into four regions: North America,
Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast in terms of value
(USD million) and volume (kg) for each of these regions along with the CAGR for the forecast
period from 2014 to 2020 have been provided in the report. A detailed qualitative analysis of the
major factors determining market dynamics such as drivers, restraints and opportunities, along
with the market attractiveness analysis are discussed in the market overview section of the
report. The study also provides a list of recommendations for new companies willing to enter the
market and for existing companies to increase market shares, which is likely to help in the
decision-making process. Event impact analysis and clinical pipeline analysis have also been
provided for albumin as an excipient in this report that will help in understanding the major
events impacting the albumin market growth. Number of clinical trials also demonstrates the
potential of albumin use as an excipient in pharmaceutical formulations.
Get Free Sample Report Albumin Market :
http://www.transparencymarketresearch.com/sample/sample.php?
flag=s&rep_id=3984
The study is a robust combination of primary and secondary research. Primary research formed
the bulk of our research efforts with information collected from telephonic interviews and
interaction via e-mails. Secondary research involved study of company websites, annual reports,
press releases, stock analysis presentations, and various international and national databases for
patents, clinical trials, demographics, disease incidence/prevalence, etc. The key players
3
Albumin Market
operating in the albumin market are CSL Behring LLC, HiMedia Laboratories Pvt. Ltd., InVitria,
MedzBio Pte. Ltd., Mitsubishi Tanabe Pharma Corporation, Novozymes A/S, Octapharma AG,
RayBiotech, Inc., Sigma-Aldrich Corporation, and Thermo Fisher Scientific.
The global albumin market is segmented as follows:
Albumin Market Revenue (USD Million), by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Albumin Market Revenue (USD Million) and Volume (kg), by Application
Drug Formulation and Drug Delivery
Vaccines
Component of Medium
Albumin Market Revenue (USD Million) and Volume (kg), by Geography
4
Albumin Market
North America
Europe
Asia Pacific
Rest of the World
TABLE OF CONTENT
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.3.2 Assumptions and Limitations
1.4 List of Abbreviations
Chapter 2 Executive Summary
5
Albumin Market
2.1 Market Snapshot: Global Albumin Market (2013 & 2020)
2.2 Comparative Analysis: Global Albumin Market Revenue, by Geography, 2013 & 2020 (Value %)
2.3 Global Albumin Market Volume, by Geography, 2012 - 2020 (Kilograms)
Chapter 3 Albumin Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Improved product stability with albumin as an excipient leading to increase in its demand
3.2.1.2 Improvements in protein purification and molecular separation technology to boost market
growth
3.2.1.3 Use of recombinant albumin to drive the albumin market
3.2.2 Restraints
3.2.2.1 Stringent regulations, cost and health care issues are anticipated to affect the market
3.2.2.2 Trend toward serum-free, specialty and customized media solutions could hamper the
albumin market
3.2.3 Opportunities
3.2.3.1 Expanding applications of albumin such as nanotechnology would revolutionize the
albumin market, particularly recombinant albumin
3.2.3.2 Focus on emerging regions to provide immense potential for the global albumin market
3.3 Porter’s Five Force Analysis for the Global Albumin Market
3.3.1 Bargaining Power of Suppliers
6
Albumin Market
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of Substitutes
3.3.4 Threat of New Entrants
3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis: Global Albumin Market, by Geography
3.5 Event Impact Analysis
3.6 Clinical Pipeline Analysis
3.7 Examples of Products Containing Albumin as an Excipient
Chapter 4 Global Albumin Market Revenue (USD Million), by Type, 2012 – 2020
4.1 Introduction
4.1.1 Global Albumin Market Revenue, by Type, 2012 - 2020 (USD Million)
4.1.2 Comparative Analysis: Global Albumin Market Revenue, by Type, 2013 & 2020 (Value %)
4.1.3 Price Range for Each Albumin Type
4.2 Human Serum Albumin (HSA)
4.2.1 Global HSA Market Revenue, 2012 – 2020 (USD Million)
4.3 Bovine Serum Albumin (BSA)
4.3.1 Global BSA Market Revenue, 2012 – 2020 (USD Million)
4.4 Recombinant Albumin (rAlbumin)
4.4.1 Global rAlbumin Market Revenue, 2012 – 2020 (USD Million)
7
Albumin Market
Chapter 5 Global Albumin Market Revenue (USD Million) and Volume (kg), by Application, 2012 - 2020
5.1 Introduction
5.1.1 Global Albumin Market Revenue, by Application, 2012 - 2020 (USD Million)
5.1.2 Comparative Analysis: Global Albumin Market Revenue, by Application, 2013 & 2020 (Value %)
5.2 Drug Formulation and Drug Delivery
5.2.1 Global Drug Formulation and Drug Delivery Market Revenue, 2012 – 2020 (USD Million)
5.2.2 Global Drug Formulation and Drug Delivery Market Volume, 2012 – 2020 (kilograms)
5.2.3 Examples of Albumin-based Drug Conjugates for Different Therapeutic Applications
5.3 Vaccines
5.3.1 Global Vaccines Market Revenue, 2012 – 2020 (USD Million)
5.3.2 Global Vaccines Market Volume, 2012 – 2020 (kilograms)
5.4 Component of Media
5.4.1 Global Component of Media Market Revenue, 2012 – 2020 (USD Million)
5.4.2 Global Component of Media Market Volume, 2012 – 2020 (kilograms)
5.4.3 Role of Albumin in Cryopreservation
5.4.4 Albumin Use in Cell Culture Media
Chapter 6 Global Albumin Market Revenue (USD Million) & Volume (kg), by Geography, 2012 - 2020
6.1 Overview
6.1.1 Global Albumin Market Revenue, by Geography, 2012 - 2020 (USD Million)
6.1.2 Global Albumin Market Volume, by Geography, 2012 - 2020 (kilograms)
8
Albumin Market
6.2 North America
6.2.1 North America Albumin Market Revenue, 2012 – 2020, (USD Million)
6.2.2 North America Albumin Market Volume, 2012 – 2020, (kilograms)
6.3 Europe
6.3.1 Europe Albumin Market Revenue, 2012 – 2020 (USD Million)
6.3.2 Europe Albumin Market Volume, 2012 – 2020 (kilograms)
6.4 Asia Pacific
6.4.1 Asia Pacific Albumin Market Revenue, 2012 – 2020 (USD Million)
6.4.2 Asia Pacific Albumin Market Volume, 2012 – 2020 (kilograms)
6.5 Rest of the World (RoW)
6.5.1 Rest of the World Albumin Market Revenue, 2012 – 2020 (USD Million)
6.5.2 Rest of the World Albumin Market Volume, 2012 – 2020 (kilograms)
Chapter 7 Recommendations
7.1 Marketing Strategies for Success
7.1.1 Investment in research and development and collaborations
7.1.2 Exploring nanotechnology applications of albumin as an excipient
7.1.3 Expansion of distribution network to strengthen position in emerging markets
7.2 Barriers to be Considered
7.2.1 Insufficient quantity of plasma and risk of disease transmission through the use of albumin as an
excipient
9
Albumin Market
7.2.2 Significant cost of investment
Chapter 8 Company Profiles
8.1 CSL Behring LLC
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 HiMedia Laboratories
8.3 InVitria (Ventria Bioscience)
10
Albumin Market
8.4 MedxBio Pte. Ltd.
8.5 Mitsubishi Tanabe Pharma
8.6 Novozymes A/S
8.7 Octapharma AG
11
Albumin Market
8.8 RayBiotech, Inc.
8.8.1 Company Overview:
8.9 Sigma-Aldrich Corporation
8.10 Thermo Fisher Scientific
List of Figures
12
Albumin Market
FIG. 1 Market Segmentation: Global Albumin Market
FIG. 2 Comparative Analysis: Global Albumin Market Revenue, by Geography, 2013 & 2020 (Value %)
FIG. 3 Global Albumin Market Volume, by Geography, 2012 - 2020 (Kilograms)
FIG. 4 Porter’s Five Forces Analysis: Global Albumin Market
FIG. 5 Market Attractiveness Analysis: Global Albumin Market, by Geography
FIG. 6 Comparative Analysis: Global Albumin Market Revenue, by Type, 2013 & 2020 (Value %)
FIG. 7 Global HSA Market Revenue, 2012 – 2020 (USD Million)
FIG. 8 Global BSA Market Revenue, 2012 – 2020 (USD Million)
FIG. 9 Global rAlbumin Market Revenue, 2012 – 2020 (USD Million)
FIG. 10 Comparative Analysis: Global Albumin Market Revenue, by Application, 2013 & 2020 (Value %)
FIG. 11 Global Drug Formulation and Drug Delivery Market Revenue, 2012 – 2020 (USD Million)
FIG. 12 Global Drug Formulation and Drug Delivery Market Volume, 2012 – 2020 (kilograms)
FIG. 13 Global Vaccines Market Revenue, 2012 – 2020 (USD Million)
FIG. 14 Global Vaccines Market Volume, 2012 – 2020 (kilograms)
FIG. 15 Global Component of Media Market Revenue, 2012 – 2020 (USD Million)
FIG. 16 Global Component of Media Market Volume, 2012 – 2020 (kilograms)
FIG. 17 North America Albumin Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 North America Albumin Market Volume, 2012 – 2020 (kilograms)
FIG. 19 Europe Albumin Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 Europe Albumin Market Volume, 2012 – 2020 (kilograms)
13
Albumin Market
FIG. 21 Asia Pacific Albumin Market Revenue, 2012 – 2020 (USD Million)
FIG. 22 Asia Pacific Albumin Market Volume, 2012 – 2020 (kilograms)
FIG. 23 Rest of the World Albumin Market Revenue, 2012 – 2020 (USD Million)
FIG. 24 Rest of the World Albumin Market Volume, 2012 – 2020 (kilograms)
FIG. 25 CSL Behring, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 26 Mitsubishi Tanabe Pharma: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 27 Novozymes: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 28 Octapharma AG: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 29 Sigma-Aldrich Corporation: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 30 Thermo Fisher Scientific: Annual Revenue, 2011 – 2013 (USD Million)
List of Tables
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Albumin Market (2013 & 2020)
TABLE 3 Event Impact Analysis: Global Albumin Market
TABLE 4 Ongoing Clinical Trials with Albumin as an Excipient
TABLE 5 Examples of Products Containing Albumin as an Excipient
TABLE 6 Global Albumin Market Revenue, by Type, 2012 - 2020 (USD Million)
TABLE 7 Price Range for Each Albumin Type (USD/ kg)
TABLE 8 Global Albumin Market Revenue, by Application, 2012 - 2020 (USD Million)
TABLE 9 Examples of Albumin-based Drug Conjugates for Different Therapeutic Applications
14
Albumin Market
TABLE 10 Global Albumin Market Revenue, by Geography, 2012 - 2020 (USD Million)
TABLE 11 Global Albumin Market Volume, by Geography, 2012 - 2020 (kilograms)
Browse All Pharmaceutical Market Research Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Us
Transparency Market Research is a market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use
proprietary data sources and various tools and techniques to gather, and analyze information. Our
business offerings represent the latest and the most reliable information indispensable for businesses to
sustain a competitive edge.
Contact
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com/
Browse The Market Research Blog :
http://researchandreports.wordpress.com/ http://www.transparencymarketresearch.com
15

Albumin Market

Transcription

Similar documents

TUTORIAL : SPECTROSCOPY NAME :

Colloids

Poszukiwanie partnerów do projektów w Programie Horyzont 2020

Certificate delivered by the European Commission, as

Document 6480153

View PDF - The Journal of Precision Medicine

Monitoring Changes in Serum Albumin Concentrations as an Early and... Potential CMX001-associated Gastrointestinal Adverse Drug Effects

registration form (full participants)

PLASMA AND ALBUMIN TRANSFUSIONS: INDICATIONS AND CONTROVERSIES Susan G. Hackner, BVSc.MRCVS.DACVIM.DACVECC.